相关实验视频
Updated: Jun 14, 2026
07:33
Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
23.2K
在KAAACI指南下语言免疫疗法
Jin-Young Min1, Hye Mi Jee2, Hwa Young Lee3
1Department of Otorhinolaryngology-Head & Neck Surgery, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Korea.
Allergy, asthma & immunology research
|January 23, 2024
概括
舌下免疫疗法 (SLIT) 是一种关键的疾病修饰治疗过敏症,如过敏性鼻炎和喘. 本指南提供专家对SLIT的见解.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 过敏原免疫疗法是对过敏性疾病 (如过敏性鼻炎和喘) 的唯一疾病修饰治疗方法.
- 舌下免疫疗法 (SLIT) 越来越多地用于过敏,作为皮下免疫疗法的可行替代品,获得临床吸引力.
- 几十年的研究支持SLIT的有效性,安全性和明确的作用机制.
研究的目的:
- 为在韩国使用语言下免疫疗法 (SLIT) 提供专家意见.
- 巩固目前关于SLIT机制,患者选择,可用的产品和安全性/有效性概况的证据.
- 为医疗保健专业人员指导SLIT在过敏疾病中的实际应用.
主要方法:
- 由过敏,儿科和耳鼻喉科专家进行的广泛文献综述.
- 基于累积的证据和专家共识的临床指南的制定.
- 专注于SLIT的实际方面,包括产品信息和患者管理.
主要成果:
- SLIT是一种成熟,安全和有效的治疗选择,用于过敏性鼻炎和喘.
- 证据支持SLIT作为皮下免疫疗法的替代方案.
- 该指南详细介绍了韩国可用的特定SLIT产品以及患者选择标准.
结论:
- 舌下免疫疗法 (SLIT) 是一种有价值的治疗选择,用于管理过敏性疾病.
- 本指南增强了临床医生对SLIT的理解和实际应用.
- SLIT提供一种疾病修饰方法,具有有利的安全性和有效性.
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...